Annual CFF
-$6.90 M
+$5.94 M+46.23%
31 December 2023
Summary:
Burning Rock Biotech Limited annual cash flow from financing activities is currently -$6.90 million, with the most recent change of +$5.94 million (+46.23%) on 31 December 2023. During the last 3 years, it has fallen by -$320.73 million (-102.20%). BNR annual CFF is now -102.20% below its all-time high of $313.82 million, reached on 31 December 2020.BNR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
30 June 2024
Summary:
Burning Rock Biotech Limited quarterly cash flow from financing activities is currently $0.00, unchanged on 30 June 2024. Over the past year, it has increased by +$6.34 million (+100.00%). BNR quarterly CFF is now -100.00% below its all-time high of $259.72 million, reached on 30 June 2020.BNR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$6.76 M
+$143.00 K+2.07%
30 June 2024
Summary:
Burning Rock Biotech Limited TTM cash flow from financing activities is currently -$6.76 million, with the most recent change of +$143.00 thousand (+2.07%) on 30 June 2024. Over the past year, it has increased by +$1.45 million (+17.66%). BNR TTM CFF is now -102.15% below its all-time high of $313.82 million, reached on 31 December 2020.BNR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.2% | +100.0% | +17.7% |
| 3 y3 years | -102.2% | +100.0% | -277.5% |
| 5 y5 years | -154.7% | +100.0% | -108.3% |
BNR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -102.2% | +46.2% | +100.0% | -277.5% | +60.9% | |
| 5 y | 5 years | -102.2% | +46.2% | -100.0% | +100.0% | -102.2% | +60.9% |
| alltime | all time | -102.2% | +46.2% | -100.0% | +100.0% | -102.2% | +60.9% |
Burning Rock Biotech Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $0.00(0.0%) | -$6.76 M(-2.1%) |
| Mar 2024 | - | $0.00(-100.0%) | -$6.90 M(-0.1%) |
| Dec 2023 | -$6.90 M(-46.2%) | -$419.10 K(-93.4%) | -$6.90 M(-15.9%) |
| Sept 2023 | - | -$6.34 M(+4331.2%) | -$8.20 M(+339.1%) |
| June 2023 | - | -$143.00 K(+2942.6%) | -$1.87 M(-84.7%) |
| Mar 2023 | - | -$4700.00(-99.7%) | -$12.22 M(-4.8%) |
| Dec 2022 | -$12.84 M(+56.7%) | -$1.72 M(>+9900.0%) | -$12.84 M(+5.3%) |
| Sept 2022 | - | -$600.00(-100.0%) | -$12.19 M(-29.5%) |
| June 2022 | - | -$10.50 M(+1596.4%) | -$17.28 M(+111.5%) |
| Mar 2022 | - | -$618.90 K(-42.3%) | -$8.17 M(-0.3%) |
| Dec 2021 | -$8.19 M | -$1.07 M(-78.9%) | -$8.19 M(-315.3%) |
| Sept 2021 | - | -$5.09 M(+266.3%) | $3.81 M(-70.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$1.39 M(+116.6%) | $13.08 M(-95.2%) |
| Mar 2021 | - | -$641.50 K(-105.9%) | $274.19 M(-12.6%) |
| Dec 2020 | $313.82 M(+279.1%) | $10.93 M(+161.2%) | $313.82 M(+3.1%) |
| Sept 2020 | - | $4.18 M(-98.4%) | $304.33 M(+3.3%) |
| June 2020 | - | $259.72 M(+566.1%) | $294.48 M(+758.5%) |
| Mar 2020 | - | $38.99 M(+2607.0%) | $34.30 M(-58.6%) |
| Dec 2019 | $82.77 M(+556.1%) | $1.44 M(-125.4%) | $82.77 M(+1.8%) |
| Sept 2019 | - | -$5.67 M(+1131.5%) | $81.33 M(-6.5%) |
| June 2019 | - | -$460.30 K(-100.5%) | $87.00 M(-0.5%) |
| Mar 2019 | - | $87.46 M | $87.46 M |
| Dec 2018 | $12.61 M(-76.0%) | - | - |
| Dec 2017 | $52.50 M | - | - |
FAQ
- What is Burning Rock Biotech Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Burning Rock Biotech Limited?
- What is Burning Rock Biotech Limited annual CFF year-on-year change?
- What is Burning Rock Biotech Limited quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Burning Rock Biotech Limited?
- What is Burning Rock Biotech Limited quarterly CFF year-on-year change?
- What is Burning Rock Biotech Limited TTM cash flow from financing activities?
- What is the all time high TTM CFF for Burning Rock Biotech Limited?
- What is Burning Rock Biotech Limited TTM CFF year-on-year change?
What is Burning Rock Biotech Limited annual cash flow from financing activities?
The current annual CFF of BNR is -$6.90 M
What is the all time high annual CFF for Burning Rock Biotech Limited?
Burning Rock Biotech Limited all-time high annual cash flow from financing activities is $313.82 M
What is Burning Rock Biotech Limited annual CFF year-on-year change?
Over the past year, BNR annual cash flow from financing activities has changed by +$5.94 M (+46.23%)
What is Burning Rock Biotech Limited quarterly cash flow from financing activities?
The current quarterly CFF of BNR is $0.00
What is the all time high quarterly CFF for Burning Rock Biotech Limited?
Burning Rock Biotech Limited all-time high quarterly cash flow from financing activities is $259.72 M
What is Burning Rock Biotech Limited quarterly CFF year-on-year change?
Over the past year, BNR quarterly cash flow from financing activities has changed by +$6.34 M (+100.00%)
What is Burning Rock Biotech Limited TTM cash flow from financing activities?
The current TTM CFF of BNR is -$6.76 M
What is the all time high TTM CFF for Burning Rock Biotech Limited?
Burning Rock Biotech Limited all-time high TTM cash flow from financing activities is $313.82 M
What is Burning Rock Biotech Limited TTM CFF year-on-year change?
Over the past year, BNR TTM cash flow from financing activities has changed by +$1.45 M (+17.66%)